| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michelle Goulette, Nicolas J Schlienz, Amy A Case, Eric Hansen, Cheryl Rivard, Rebecca L Ashare, Maciej L Goniewicz, Maansi Bansal-Travers, Andrew Hyland, Danielle M Smit. Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. vol 32. issue 4. 2024-03-05. PMID:38443674. |
this study aimed to examine knowledge of thc or cbd concentration among patients living with cancer who consume cannabis, and factors associated with knowledge of cannabinoid concentrations. |
2024-03-05 |
2024-03-08 |
Not clear |
| Melody Cui Sun, Almudena Otálora-Alcaraz, Jack A Prenderville, Eric J Downe. Toll-like receptor signalling as a cannabinoid target. Biochemical pharmacology. 2024-03-04. PMID:38438052. |
cannabinoids include component of the plant cannabis sativa l. (c. sativa), synthetic and endogenous ligands, and overall represent a class of compounds whose therapeutic potential and mechanism of action continues to be elucidated. |
2024-03-04 |
2024-03-07 |
Not clear |
| Avanti Puri, Filippo Costanzo, Janny Rivera, Jean Bujdo. Catatonia Induced by First-Time Use of Synthetic Cannabinoids: A Case Report. Cureus. vol 16. issue 1. 2024-03-04. PMID:38435863. |
in this case report, we present one of the first cases of catatonia induced by first-time synthetic cannabinoids with no previous history of cannabis use disorder. |
2024-03-04 |
2024-03-06 |
Not clear |
| Irma Castro-Navarro, Mark A McGuire, Janet E Williams, Elizabeth A Holdsworth, Courtney L Meehan, Michelle K McGuir. Maternal cannabis use during lactation and potential effects on human milk composition and production: a narrative review. Advances in nutrition (Bethesda, Md.). 2024-03-03. PMID:38432590. |
several studies have demonstrated that cannabinoids and their metabolites are detectable in human milk produced by mothers who use cannabis. |
2024-03-03 |
2024-03-06 |
human |
| Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. |
cannabidiol (cbd) is a non-intoxicating cannabinoid recognised for its anticonvulsant, anxiolytic and antipsychotic effects with no habit-forming qualities. |
2024-03-03 |
2024-03-06 |
Not clear |
| Sabrina Bimonte, Davide Nocerino, Daniela Schiavo, Marco Crisci, Marco Cascella, Arturo Cuom. Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives. Anticancer research. vol 44. issue 3. 2024-02-29. PMID:38423660. |
unfortunately, opioid treatment causes side effects and inefficiently relieves patients from pain, therefore alternative therapies have been considered, including cannabis sativa and cannabinoids. |
2024-02-29 |
2024-03-03 |
Not clear |
| Sabrina Bimonte, Davide Nocerino, Daniela Schiavo, Marco Crisci, Marco Cascella, Arturo Cuom. Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives. Anticancer research. vol 44. issue 3. 2024-02-29. PMID:38423660. |
accumulating evidence has highlighted that an increasing number of patients are choosing to use cannabis and cannabinoids for the management of their soothing and non-palliative cancer pain and other cancer-related symptoms. |
2024-02-29 |
2024-03-03 |
Not clear |
| Radhika Anand, Ritu Painuli, Vijay Kumar, Parvinder Pal Sing. Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids? European journal of medicinal chemistry. vol 268. 2024-02-28. PMID:38417219. |
cannabinoids have emerged as compelling candidates for medicinal applications, notably following the recent approval of non-psychoactive cannabidiol (cbd) as a medicine. |
2024-02-28 |
2024-03-02 |
human |
| Jenny L Wiley, Julie A Marusich, Bruce E Blough, Ojas Namjoshi, Marcus Brackeen, Luli R Akinfiresoye, Teneille D Walker, Cassandra Prioleau, Daniel G Barrus, Thomas F Gamag. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Progress in neuro-psychopharmacology & biological psychiatry. 2024-02-28. PMID:38417478. |
the cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. |
2024-02-28 |
2024-03-02 |
mouse |
| J J Rosado-Franco, A L Ellison, C J White, A S Price, C F Moore, R E Williams, L B Fridman, E M Weerts, D W William. Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models. Physiological reports. vol 12. issue 4. 2024-02-28. PMID:38408761. |
increasing interest in the endocannabinoid system has arisen due to these physiologic roles, policy changes leading to more widespread recreational use, and the therapeutic potential of cannabis and phytocannabinoids. |
2024-02-28 |
2024-03-01 |
mouse |
| Michael W Degregorio, Chiao-Jung Kao, Gregory T Wur. Complexity of Translating Analytics to Recent Cannabis Use and Impairment. Journal of AOAC International. 2024-02-27. PMID:38410076. |
a new testing approach has been developed based on exhaled breath and blood sampling that incorporates kinetic changes and the presence of key cannabinoids to detect recent cannabis use within the impairment window without the false positive results seen with other methods. |
2024-02-27 |
2024-03-02 |
human |
| Amy L Cherry, Michael J Wheeler, Karolina Mathisova, Mathieu Di Micel. Frontiers in neuroinformatics. vol 18. 2024-02-26. PMID:38404644. |
the endocannabinoid (ecb) system is named after the discovery that endogenous cannabinoids bind to the same receptors as the phytochemical compounds found in cannabis. |
2024-02-26 |
2024-02-28 |
Not clear |
| Amy L Cherry, Michael J Wheeler, Karolina Mathisova, Mathieu Di Micel. Frontiers in neuroinformatics. vol 18. 2024-02-26. PMID:38404644. |
while endogenous cannabinoids include anandamide (aea) and 2-arachidonoylglycerol (2-ag), exogenous phytocannabinoids include Δ-9 tetrahydrocannabinol (thc) and cannabidiol (cbd). |
2024-02-26 |
2024-02-28 |
Not clear |
| Emese Kroon, Janna Cousijn, Francesca Filbey, Christian Berchtold, Tina M Binz, Lauren Kuhn. Associations between hair-derived cannabinoid levels, self-reported use, and cannabis-related problems. Psychopharmacology. 2024-02-26. PMID:38407636. |
as cannabis potency and cannabis use are increasing in newly legalized markets, it is increasingly important to measure and examine the effects of cannabinoid exposure. |
2024-02-26 |
2024-02-28 |
Not clear |
| Luana Barreto Domingos, Heidi Kaastrup Müller, Nicole Rodrigues da Silva, Michaela D Filiou, Anders Lade Nielsen, Francisco Silveira Guimarães, Gregers Wegener, Sâmia Joc. Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression. Neuropharmacology. 2024-02-24. PMID:38401791. |
repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the flinders sensitive line (fsl) rat model of depression. |
2024-02-24 |
2024-02-27 |
rat |
| Pedro Wong-Salgado, Fabiano Soares, Jeel Moya-Salazar, José F Ramírez-Méndez, Marcia M Moya-Salazar, Alfonso Apesteguía, Americo Castr. Therapeutic Potential of Cannabinoid Profiles Identified in Biomedicines. vol 12. issue 2. 2024-02-24. PMID:38397908. |
therapeutic potential of cannabinoid profiles identified in cannabis is a plant that is cultivated worldwide, and its use is internationally regulated, but some countries have been regulating its medicinal, social, and industrial uses. |
2024-02-24 |
2024-02-26 |
Not clear |
| Pedro Wong-Salgado, Fabiano Soares, Jeel Moya-Salazar, José F Ramírez-Méndez, Marcia M Moya-Salazar, Alfonso Apesteguía, Americo Castr. Therapeutic Potential of Cannabinoid Profiles Identified in Biomedicines. vol 12. issue 2. 2024-02-24. PMID:38397908. |
cannabis contains specific metabolites known as cannabinoids, some of which have clinically demonstrated therapeutic effects. |
2024-02-24 |
2024-02-26 |
Not clear |
| Pedro Wong-Salgado, Fabiano Soares, Jeel Moya-Salazar, José F Ramírez-Méndez, Marcia M Moya-Salazar, Alfonso Apesteguía, Americo Castr. Therapeutic Potential of Cannabinoid Profiles Identified in Biomedicines. vol 12. issue 2. 2024-02-24. PMID:38397908. |
this study analyzed the chemotypes of eight samples of dried inflorescences from cannabis cultivars in four different regions of peru, and based on the significant variation in the cannabinoid profiles, we suggest their therapeutic potential. |
2024-02-24 |
2024-02-26 |
Not clear |
| Roua A Nouh, Ahmed Kamal, Oluwaseyi Oyewole, Walaa A Abbas, Bishoy Abib, Abdelrouf Omar, Somaia T Mansour, Anwar Abdelnase. Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine. Pharmaceutics. vol 16. issue 2. 2024-02-24. PMID:38399295. |
this review will examine the traditional treatment for multiple sclerosis, the increasing interest in using cannabis as a treatment method, its role in protecting the nervous system and regulating the immune system, commercially available therapeutic cannabinoids, and the emerging use of cannabis in nanomedicine. |
2024-02-24 |
2024-02-26 |
Not clear |
| Jennifer L Joffray, Deborah Johnso. The need for cannabis education in dental hygiene programs. Journal of dental education. 2024-02-24. PMID:38400647. |
cannabis and the endocannabinoid system (esc) are rarely included in training programs for healthcare providers. |
2024-02-24 |
2024-02-26 |
Not clear |